Research Discovery Platform | Access African Health Data Easily

Research & Discovery Access

Accelerate discovery with access to high-quality African biospecimens and research-ready datasets. Accelerate precision cohort discovery , source compliant samples, and support studies efficiently, ethically and at scale.

The Discovery Bottleneck

Effective discovery programs require diverse, well-characterized datasets that reflect populations from around the world. While Africa is one of the most genetically rich and clinically diverse regions, biotech companies, pharmaceutical firms, and academic researchers often spend months, sometimes years, trying to access high-quality datasets that are standardized and research-ready.

BioVana bridges this gap by working with hospitals and biobanks to structure and prepare datasets for global research, creating trusted pathways for researchers to identify relevant cohorts and access compliant datasets and biospecimens efficiently and ethically.

What You Gain

FAIR-Compliant Data

Access datasets that are Findable, Accessible, Interoperable, and Reusable, enabling your teams to identify relevant cohorts faster and integrate external data into discovery workflows.

OMOP-Aligned Datasets

Work with standardized clinical datasets structured in alignment with the OMOP common data model, making it easier to integrate data into your analytics pipelines, multi-site studies, and AI models.

Faster Discovery & Validation

Spend less time cleaning and preparing data. Access research-ready datasets and biospecimens that accelerate biomarker discovery, validation studies, and translational research.

How We Accelerate Trials

From site discovery to enrollment, we remove the friction—while protecting sovereignty.

For Pharma & Biotech

Identify African sites with ISO 20387-certified biobanks
Access aggregated cohort data without individual-level exposure
Request data briefs on population genetics and disease prevalence
Partner with sites under fair, transparent governance terms

For CROs & Academia

Search BioVana Index for available samples and cohorts
Connect with African researchers for collaborative trials
Access standardized MIABIS/OMOP data for protocol design
Leverage certified sites to meet regulatory requirements

For African Sites

Showcase your capabilities to global research networks
Receive trial opportunities aligned with your expertise
Negotiate partnerships from a position of strength and sovereignty
Generate revenue while advancing African health priorities

Real Impact

A European biotech needed 500 African participants for a malaria vaccine trial.

Using BioVana Index, they discovered three ISO-certified sites in West Africa with existing malaria cohorts—fully consented, well-characterized, and ready to enroll.

Timeline before BioVana: 18 months to identify sites, negotiate terms, and start enrollment.

Timeline with BioVana: 6 weeks.

The sites retained data governance. The sponsor got access to diverse genetics. African researchers co-authored the findings. Everyone won.